Drug Trials, Doctors, and Developing Countries: Toward a Legal Definition of Informed Consent


Abstract
Assume this hypothetical situation: an American pharmaceutical company, Maxwell Fisch Pharmaceuticals, Inc., wishes to perform clinical trials involving a new antipsychotic medication, Klezac. Klezac is in its third phase of the clinical stage of the drug research process. Once the testing is complete, Maxwell plans to submit a New Drug Application, the official request to begin marketing Klezac, to the Food and Drug Administration. The new drug is expected to receive FDA approval in 2 or more years. The company decides to shift its research and development activities to Z, a small, developing country. In doing so, Maxwell is following the course taken by numerous other drug companies who wish to take advantage of faster governmental approval in foreign sites and ensuing cheaper research costs
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1017/s0963180100007192
Options
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

Our Archive


Upload a copy of this paper     Check publisher's policy     Papers currently archived: 47,182
Through your library

References found in this work BETA

View all 7 references / Add more references

Citations of this work BETA

No citations found.

Add more citations

Similar books and articles

Autonomy, Consent and the Law.Sheila McLean - 2010 - Routledge-Cavendish.
Informed Consent and the Requirement to Ensure Understanding.Tom Walker - 2012 - Journal of Applied Philosophy 29 (1):50-62.

Analytics

Added to PP index
2010-08-24

Total views
12 ( #698,247 of 2,289,504 )

Recent downloads (6 months)
1 ( #838,743 of 2,289,504 )

How can I increase my downloads?

Downloads

My notes

Sign in to use this feature